Show
Sort by
-
- Journal Article
- A1
- open access
Assessment of cardiovascular safety of anti-osteoporosis drugs
-
- Journal Article
- A1
- open access
Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength : state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
-
- Journal Article
- A1
- open access
Algorithm for the use of biochemical markers of bone turnover in the diagnosis, assessment and follow-up of treatment for osteoporosis
-
- Journal Article
- A1
- open access
Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment : results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)
-
- Journal Article
- A1
- open access
Effects of 24 months of treatment with romosozumab followed by 12 months of denosumab or placebo in postmenopausal women with low bone mineral density : a randomized, double-blind, phase 2, parallel group study
-
Patients' preferences for anti-osteoporosis drug treatment : a cross-European discrete choice experiment
-
Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data: an expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
-
Treatment of osteoporosis in men
-
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis
-
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men